An Ad5 [E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice

Por Gabitzsch, Elizabeth S., Xu, Younong, Balcaitis, Stephanie, Balint, Joseph P., Jones, Frank R.
Publicado em 2011

Induction and Comparison of SIV immunity in Ad5 Naïve and Ad5 Immune Non-human Primates using an Ad5 [E1-, E2b-] based vaccine

Por Gabitzsch, Elizabeth S, Xu, Younong, Balint, Joseph P, Balcaitis, Stephanie, Sanders-Beer, Brigitte, Jones, Frank R
Publicado em 2011

Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform

Por Gabitzsch, Elizabeth S., Balint-Junior, Joseph P., Xu, Younong, Balcaitis, Stephanie, Sanders-Beer, Brigitte, Karl, Julie, Weinhold, Kent J., Paessler, Slobodan, Jones, Frank R.
Publicado em 2012

NKG2D ligand expression in pediatric brain tumors

Por Haberthur, Kristen, Brennan, Kathryn, Hoglund, Virginia, Balcaitis, Stephanie, Chinn, Harrison, Davis, Amira, Kreuser, Shannon, Winter, Conrad, Leary, Sarah E.S., Deutsch, Gail H., Ellenbogen, Richard G., Crane, Courtney A.
Publicado no Cancer Biol Ther (2016)

A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors

Por Wieking, Bryant G., Vermeer, Daniel W., Spanos, William C., Lee, Kimberly M., Vermeer, Paola, Lee, Walter T., Xu, Younong, Gabitzsch, Elizabeth S., Balcaitis, Stephanie, Balint, Joseph P., Jones, Frank R., Lee, John H.
Publicado em 2012

Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients

Por Morse, Michael A., Chaudhry, Arvind, Gabitzsch, Elizabeth S., Hobeika, Amy C., Osada, Takuya, Clay, Timothy M., Amalfitano, Andrea, Burnett, Bruce K., Devi, Gayathri R., Hsu, David S., Xu, Younong, Balcaitis, Stephanie, Dua, Rajesh, Nguyen, Susan, Balint, Joseph P., Jones, Frank R., Lyerly, H. Kim
Publicado em 2013